tykhr
sign in
free sign up
Actinium Pharmaceuticals Inc
Biotechnology
Healthcare
ATNM
31.20 M shares
NYSE MKT US
traded
23 Sep 2025
listed
no
open
1.66
52 week high
1.94
high
1.66
52 week low
0.00
low
1.56
growth
12.50 %
previous Close
1.63
P/E ratio
market cap
56.78 M
div yield
0
usd
Jun 2025
qoq
revenue
0.00 %
net incoming
0.00 %
eps
0.00 %
0.00 %
eps surprise
100.00 %
net profit margin
0.00 %
0.00 %
operating incoming
0.00 %
net change in cash
0.00 %
cash on hand
0.00 %
cost of revenue
0.00 %
top